Business  >  CASE STUDY  >  Pathopharm_Foundations_paper.docx C155 Pathopharmacological Foundations (All)

Pathopharm_Foundations_paper.docx C155 Pathopharmacological Foundations

Document Content and Description Below

Pathopharm_Foundations_paper.docx C155 Pathopharmacological Foundations C155 WUT2 Task WGU A. Investigated Disease Process. The term ob ... esity can be described as having a body mass index greater than 30. Although obesity is not considered a disease, it affects one third of American adults. Obesity brings along with it the opportunity for multiple co-morbidities. Obesity has serious genetic implications along with environmental factors contributing to the health disparity. Obesity has been on the rise in the United States for the last 20 years and has reached epidemic proportions ("CDC," 2018, p. 9). A1. Pathophysiology. Obesity being defined as a body mass index exceeding 30, occurs when the body is in a constant state of caloric excess. This occurs when an individual consumes more calories than the body requires to maintain homeostasis. Multiple diseases are associated with obesity including, hypertension, diabetes, cardiovascular disease and also death. The process of obesity is very complicated and includes the involvement of cytokines, hormones, and neurotransmitters. Satiety signals are disrupted in the neuroendocrine system. Multiple factors are considered contributory to obesity including genetics, environment, and inactive lifestyles. Leptins levels react in the hypothalamus which regulate appetite control and regulate body weight. Disruption in these levels have been linked to obesity genes and obesity in general (McCance & Hu. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. .. . . . . . . . . . . . . . . . . . .. . . . . [Show More]

Last updated: 3 years ago

Preview 1 out of 15 pages

Buy Now

Instant download

We Accept:

Payment methods accepted on Scholarfriends (We Accept)
Preview image of Pathopharm_Foundations_paper.docx  C155  Pathopharmacological Foundations document

Buy this document to get the full access instantly

Instant Download Access after purchase

Buy Now

Instant download

We Accept:

Payment methods accepted on Scholarfriends (We Accept)

Reviews( 0 )

$10.00

Buy Now

We Accept:

Payment methods accepted on Scholarfriends (We Accept)

Instant download

Can't find what you want? Try our AI powered Search

86
0

Document information


Connected school, study & course


About the document


Uploaded On

Jun 12, 2022

Number of pages

15

Written in

All

Seller


Profile illustration for helperatsof1
helperatsof1

Member since 4 years

48 Documents Sold

Reviews Received
1
0
0
0
2
Additional information

This document has been written for:

Uploaded

Jun 12, 2022

Downloads

 0

Views

 86

Document Keyword Tags

Recommended For You

Get more on CASE STUDY »

$10.00
What is Scholarfriends

Scholarfriends.com Online Platform by Browsegrades Inc. 651N South Broad St, Middletown DE. United States.

We are here to help

We're available through e-mail, Twitter, Facebook, and live chat.
 FAQ
 Questions? Leave a message!

Follow us on
 Twitter

Copyright © Scholarfriends · High quality services·